Tecan Group（TECN）株式概要
テカングループAGは、バイオ医薬品、法医学、臨床診断のラボラトリー機器とソリューションをヨーロッパ、北米、アジア、そして国際的に提供しています。 詳細
TECN Community Fair Values
Create NarrativeSee what 9 others think this stock is worth. Follow their fair value or set your own to get alerts.
Analyst Price Targets
Tecan Group AG 競合他社
価格と性能
| 過去の株価 | |
|---|---|
| 現在の株価 | CHF 148.00 |
| 52週高値 | CHF 177.50 |
| 52週安値 | CHF 110.60 |
| ベータ | 1.01 |
| 1ヶ月の変化 | 7.79% |
| 3ヶ月変化 | 7.32% |
| 1年変化 | -12.22% |
| 3年間の変化 | -58.33% |
| 5年間の変化 | -66.07% |
| IPOからの変化 | 215.57% |
最新ニュース
ナラティブの更新 • May 02
TECN: Updated Discount Assumptions Will Shape Perceived Upside Potential
Tecan Group's analyst price target has been reduced by CHF 1 to CHF 136, as analysts factor in updated discount rate and valuation assumptions, along with modest adjustments to revenue growth, profit margin and future P/E inputs. Analyst Commentary Recent research points to a more cautious tone around Tecan Group, with reduced price targets reflecting reassessed assumptions on growth, profitability and valuation multiples.
ナラティブの更新 • Apr 18
TECN: AI Lab Collaboration And Execution Discipline Will Support Future Earnings
The analyst price target for Tecan Group has shifted slightly to around CHF 167, with recent CHF 1 and CHF 17 target reductions from different firms. These moves have led analysts to fine tune assumptions on discount rate, revenue growth, profit margin and future P/E, without changing the overall valuation picture in a major way.ナラティブの更新 • Apr 03
TECN: Mixed Research Views And 2026 Guidance Shape Forward Expectations
Analysts have trimmed their average price target on Tecan Group to CHF 205, a CHF 17 reduction from recent levels. This reflects updated views on discount rates, revenue growth, profit margins and future P/E assumptions following mixed target moves across the Street.Recent updates
ナラティブの更新 • May 02
TECN: Updated Discount Assumptions Will Shape Perceived Upside Potential
Tecan Group's analyst price target has been reduced by CHF 1 to CHF 136, as analysts factor in updated discount rate and valuation assumptions, along with modest adjustments to revenue growth, profit margin and future P/E inputs. Analyst Commentary Recent research points to a more cautious tone around Tecan Group, with reduced price targets reflecting reassessed assumptions on growth, profitability and valuation multiples.ナラティブの更新 • Apr 18
TECN: AI Lab Collaboration And Execution Discipline Will Support Future Earnings
The analyst price target for Tecan Group has shifted slightly to around CHF 167, with recent CHF 1 and CHF 17 target reductions from different firms. These moves have led analysts to fine tune assumptions on discount rate, revenue growth, profit margin and future P/E, without changing the overall valuation picture in a major way.ナラティブの更新 • Apr 03
TECN: Mixed Research Views And 2026 Guidance Shape Forward Expectations
Analysts have trimmed their average price target on Tecan Group to CHF 205, a CHF 17 reduction from recent levels. This reflects updated views on discount rates, revenue growth, profit margins and future P/E assumptions following mixed target moves across the Street.ナラティブの更新 • Mar 20
TECN: AI Lab Collaboration Will Support Forward Efficiency Gains And Earnings
The updated analyst price target for Tecan Group moves to CHF 166.50 from CHF 192.57, reflecting mixed Street views as some analysts trim targets while others highlight support from higher assumed revenue growth and a slightly lower future P/E multiple. Analyst Commentary Recent Street research on Tecan Group points to a split view, with some analysts trimming price targets and others turning more constructive on the shares.ナラティブの更新 • Mar 05
TECN: Mixed Research Views And Investor Day Outlook Shape Future Expectations
Analysts have trimmed their price target for Tecan Group to CHF 137.00 from CHF 165.20, reflecting updated assumptions around discount rates, revenue growth, profit margins and future P/E. Recent research also includes both a Morgan Stanley target cut and target and rating adjustments from other firms.
ナラティブの更新 • Feb 19
TECN: Recent Upgrade And CHF 205 Goal Will Support Higher Long Term P/E
Analysts have nudged their price targets on Tecan Group slightly lower, with moves such as Morgan Stanley trimming its target by CHF 5 and others, including Bernstein and Berenberg, adjusting their outlooks. These revisions have led to only marginal changes in modeled fair value, discount rate, revenue growth, profit margin, and future P/E assumptions.ナラティブの更新 • Feb 05
TECN: CFO Transition And Execution Will Support Higher Long Term P/E Potential
Analysts have nudged their price expectations for Tecan Group slightly higher, with the updated fair value estimate moving from CHF 334.71 to about CHF 335.08. This reflects small model adjustments to growth, margins and long term P/E assumptions after recent mixed target moves from banks that both lowered and raised their CHF based price targets.ナラティブの更新 • Jan 22
TECN: Execution And CFO Transition Will Support Upgraded Outlook And Medium Term Upside
Narrative Update The analyst price target for Tecan Group has been revised to CHF 205 from CHF 200. Analysts cite updated assumptions on growth, profitability and a higher future P/E multiple as the main factors behind this change.ナラティブの更新 • Jan 08
TECN: Efficiency Gains And Gradual Market Recovery Will Support Forward Earnings
Analysts have trimmed their price target on Tecan Group to about CHF 193 from around CHF 202, reflecting slightly lower fair value estimates, supported by recent target reductions such as the move to CHF 170 cited in Street research. Analyst Commentary Recent Street commentary around Tecan Group points to a more cautious stance, with price targets being reset closer to CHF 170, which sits below the trimmed average around CHF 193.分析記事 • Dec 23
Does Tecan Group (VTX:TECN) Have A Healthy Balance Sheet?
Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...ナラティブの更新 • Dec 14
TECN: Medium Term Execution And CFO Transition Will Support Future Upside Potential
Analysts have lowered their price target on Tecan Group to CHF 170 from CHF 177, reflecting a slightly higher discount rate despite modestly improved revenue growth and profit margin expectations. Analyst Commentary Bullish analysts acknowledge the modest reduction in the price target but view the revised CHF 170 level as still supportive of upside potential from current trading levels, given improving fundamentals and execution.ナラティブの更新 • Nov 30
TECN: Efficiency Gains And Market Recovery Will Drive Forward Earnings Improvements
Analysts have reduced their price target for Tecan Group from CHF 177 to CHF 170. They cited revised market assumptions and modest adjustments to key financial forecasts as reasons for this change.ナラティブの更新 • Nov 16
TECN: Automation Demand And Partnerships Will Drive Earnings Recovery After 2026
Tecan Group: Analyst Price Target Reduced on Updated Outlook Analysts have lowered their fair value estimate for Tecan Group from CHF 205.98 to CHF 202.48. They cited slightly higher discount rates and tempered expectations for revenue growth and profit margins as reasons for the change.分析記事 • Nov 06
Tecan Group AG's (VTX:TECN) Intrinsic Value Is Potentially 90% Above Its Share Price
Key Insights Using the 2 Stage Free Cash Flow to Equity, Tecan Group fair value estimate is CHF261 Tecan Group's CHF138...ナラティブの更新 • Nov 01
TECN: Resilient Demand And Share Repurchase Program Will Drive Shareholder Value
The analyst price target for Tecan Group has been revised downward from CHF 177 to CHF 170. Analysts cite slightly softer revenue growth expectations and a modest increase in the discount rate in their updated assessments.分析記事 • Oct 22
Should You Investigate Tecan Group AG (VTX:TECN) At CHF150?
Tecan Group AG ( VTX:TECN ), is not the largest company out there, but it saw significant share price movement during...ナラティブの更新 • Oct 18
Advanced Automation And Personalized Medicine Will Shape Healthcare's Future
Tecan Group's updated analyst fair value price target has been revised downward from CHF 215.73 to CHF 207.23. This change reflects cautious analyst views amid slower revenue growth and tightened profit margin expectations.ナラティブの更新 • Oct 04
Advanced Automation And Personalized Medicine Will Shape Healthcare's Future
Analysts have adjusted their price target for Tecan Group downward, reducing the fair value estimate from CHF 220.47 to CHF 215.73. This change is due to a slight increase in the discount rate, although forecasts for revenue growth and profit margins have improved.ナラティブの更新 • Sep 05
Advanced Automation And Personalized Medicine Will Shape Healthcare's Future
Analysts have lowered their outlook for Tecan Group due to concerns over near-term margin pressure, cautious end-market demand, and delayed recovery in key segments, though the consensus price target remained unchanged at CHF220.47. Analyst Commentary Cautious sentiment due to anticipation of "soft" first-half financial results impacting near-term performance.分析記事 • Sep 04
Tecan Group (VTX:TECN) Has A Pretty Healthy Balance Sheet
David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...分析記事 • Aug 20
Weak Statutory Earnings May Not Tell The Whole Story For Tecan Group (VTX:TECN)
SWX:TECN 1 Year Share Price vs Fair Value Explore Tecan Group's Fair Values from the Community and select yours The...分析記事 • Aug 08
Tecan Group AG's (VTX:TECN) Intrinsic Value Is Potentially 81% Above Its Share Price
Key Insights Tecan Group's estimated fair value is CHF281 based on 2 Stage Free Cash Flow to Equity Current share price...分析記事 • Jul 21
Why We're Not Concerned About Tecan Group AG's (VTX:TECN) Share Price
When close to half the companies in Switzerland have price-to-earnings ratios (or "P/E's") below 20x, you may consider...分析記事 • May 28
At CHF170, Is Tecan Group AG (VTX:TECN) Worth Looking At Closely?
While Tecan Group AG ( VTX:TECN ) might not have the largest market cap around , it saw a significant share price rise...分析記事 • Apr 24
Is Tecan Group AG (VTX:TECN) Trading At A 26% Discount?
Key Insights Tecan Group's estimated fair value is CHF199 based on 2 Stage Free Cash Flow to Equity Tecan Group is...分析記事 • Apr 08
Tecan Group AG (VTX:TECN) Shares Slammed 25% But Getting In Cheap Might Be Difficult Regardless
To the annoyance of some shareholders, Tecan Group AG ( VTX:TECN ) shares are down a considerable 25% in the last...分析記事 • Apr 04
Here's Why Shareholders Should Examine Tecan Group AG's (VTX:TECN) CEO Compensation Package More Closely
Key Insights Tecan Group will host its Annual General Meeting on 10th of April Total pay for CEO Achim von Leoprechting...分析記事 • Apr 01
Is Tecan Group (VTX:TECN) Using Too Much Debt?
David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...
新しいナラティブ • Mar 16
Expansion Into South Korea And FDA Approval To Support Future High-Value Medical Device Production
Expansion into South Korea and FDA approval in Malaysia bolster Tecan's production and revenue growth potential in medical devices.分析記事 • Jan 12
Tecan Group AG's (VTX:TECN) Share Price Could Signal Some Risk
When close to half the companies in Switzerland have price-to-earnings ratios (or "P/E's") below 20x, you may consider...分析記事 • Dec 21
A Look At The Fair Value Of Tecan Group AG (VTX:TECN)
Key Insights Using the 2 Stage Free Cash Flow to Equity, Tecan Group fair value estimate is CHF231 With CHF198 share...分析記事 • Oct 09
Tecan Group AG's (VTX:TECN) P/E Still Appears To Be Reasonable
With a price-to-earnings (or "P/E") ratio of 33.7x Tecan Group AG ( VTX:TECN ) may be sending very bearish signals at...分析記事 • Sep 21
These 4 Measures Indicate That Tecan Group (VTX:TECN) Is Using Debt Reasonably Well
Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...分析記事 • Aug 16
Earnings Report: Tecan Group AG Missed Revenue Estimates By 8.8%
It's been a sad week for Tecan Group AG ( VTX:TECN ), who've watched their investment drop 13% to CHF280 in the week...分析記事 • Jun 14
Is Tecan Group (VTX:TECN) Using Too Much Debt?
Warren Buffett famously said, 'Volatility is far from synonymous with risk.' So it might be obvious that you need to...分析記事 • Apr 20
Calculating The Fair Value Of Tecan Group AG (VTX:TECN)
Key Insights Tecan Group's estimated fair value is CHF409 based on 2 Stage Free Cash Flow to Equity Current share price...分析記事 • Apr 02
Tecan Group AG's (VTX:TECN) Business Is Yet to Catch Up With Its Share Price
With a price-to-earnings (or "P/E") ratio of 36.2x Tecan Group AG ( VTX:TECN ) may be sending very bearish signals at...株主還元
| TECN | CH Life Sciences | CH 市場 | |
|---|---|---|---|
| 7D | 11.1% | 3.7% | 1.4% |
| 1Y | -12.2% | -6.4% | 8.0% |
業界別リターン: TECN過去 1 年間で-6.4 % の収益を上げたSwiss Life Sciences業界を下回りました。
リターン対市場: TECNは、過去 1 年間で8 % のリターンを上げたSwiss市場を下回りました。
価格変動
| TECN volatility | |
|---|---|
| TECN Average Weekly Movement | 6.0% |
| Life Sciences Industry Average Movement | 6.0% |
| Market Average Movement | 4.6% |
| 10% most volatile stocks in CH Market | 8.2% |
| 10% least volatile stocks in CH Market | 2.4% |
安定した株価: TECN 、 Swiss市場と比較して、過去 3 か月間で大きな価格変動はありませんでした。
時間の経過による変動: TECNの 週次ボラティリティ ( 6% ) は過去 1 年間安定しています。
会社概要
| 設立 | 従業員 | CEO（最高経営責任者 | ウェブサイト |
|---|---|---|---|
| 1980 | 3,166 | Monica Manotas | www.tecan.com |
テカングループAGは、バイオ医薬品、法医学、臨床診断におけるラボラトリー機器とソリューションをヨーロッパ、北米、アジア、そして国際的に提供している。ライフサイエンス事業とパートナー事業の2つのセグメントで事業を展開。同社は、リキッドハンドリングと自動化、マイクロプレートリーダーと洗浄機、ソフトウェア、消耗品、NGS試薬、イムノアッセイと抗体、およびエンドツーエンドの自動化ソリューションであるTecan Labwerxを提供している。また、設計・製造受託サービスのPARAMIT、カスタマイズOEMシステムのSynergence、標準およびカスタマイズOEMコンポーネントのCavro、オンサイトおよびデポ修理、リモートサービス、デジタルソリューションも提供している。同社は1980年に設立され、スイスのメーネドルフに本社を置いている。
Tecan Group AG 基礎のまとめ
| TECN 基礎統計学 | |
|---|---|
| 時価総額 | CHF 1.86b |
| 収益（TTM） | -CHF 110.65m |
| 売上高(TTM) | CHF 882.48m |
2.1x
P/Sレシオ-16.8x
PER（株価収益率TECN は割高か？
公正価値と評価分析を参照収益と収入
| TECN 損益計算書（TTM） | |
|---|---|
| 収益 | CHF 882.48m |
| 売上原価 | CHF 571.64m |
| 売上総利益 | CHF 310.84m |
| その他の費用 | CHF 421.49m |
| 収益 | -CHF 110.65m |
直近の収益報告
Dec 31, 2025
次回決算日
Aug 11, 2026
| 一株当たり利益（EPS） | -8.83 |
| グロス・マージン | 35.22% |
| 純利益率 | -12.54% |
| 有利子負債／自己資本比率 | 13.1% |
TECN の長期的なパフォーマンスは？
過去の実績と比較を見る配当金
2.0%
現在の配当利回り-34%
配当性向企業分析と財務データの現状
| データ | 最終更新日（UTC時間） |
|---|---|
| 企業分析 | 2026/05/21 04:56 |
| 終値 | 2026/05/21 00:00 |
| 収益 | 2025/12/31 |
| 年間収益 | 2025/12/31 |
データソース
企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。
| パッケージ | データ | タイムフレーム | 米国ソース例 |
|---|---|---|---|
| 会社財務 | 10年 |
| |
| アナリストのコンセンサス予想 | +プラス3年 |
|
|
| 市場価格 | 30年 |
| |
| 所有権 | 10年 |
| |
| マネジメント | 10年 |
| |
| 主な進展 | 10年 |
|
* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。
特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。
分析モデルとスノーフレーク
本レポートを生成するために使用した分析モデルの詳細は当社のGithubページでご覧いただけます。また、レポートの使用方法に関するガイドやYoutubeのチュートリアルも掲載しています。
シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。
業界およびセクターの指標
私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。
アナリスト筋
Tecan Group AG 8 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。18
| アナリスト | 機関 |
|---|---|
| Harry Gillis | Berenberg |
| Delphine Le Louet | Bernstein |
| Susannah Ludwig | Bernstein |